Licensed Pharmacies
Fully Online Care
Free Expedited Delivery
Dedicated Clinical Team
HSA/FSA Accepted
Same-Day Doctor Visits

Ozari vs Henry Meds: Both Bill Flat — One Starts at $179, One at $86

Published August 9, 2026

Henry Meds and Ozari agree on the argument and disagree on the number. Both sell compounded GLP-1s through licensed US pharmacies. Both bundle the provider visit, the medication, the supplies, and the follow-up into a single flat monthly price with no membership fee. Henry's own FAQ says its GLP-1 plans start at $179/month. Ozari's semaglutide starter is $86. Same structure, $93 apart, every month.

What Henry Meds Publicly Lists

As of August 2026, henrymeds.com states that GLP-1 pricing "varies by treatment plan and dosing, but starts at $179/month," and that this "includes the cost of your provider visits, medication, supplies, and ongoing support." Henry offers compounded semaglutide, liraglutide, and tirzepatide, in both injectable and oral formats.

Ozari's true-cost tracker, verified July 2026, has listed additional detail: injectable semaglutide at $247–$297/month, with the $247 rate requiring a 12-month commitment and $297 for month-to-month; a $147 first month; oral semaglutide at $199/month; oral tirzepatide at $299/month; and consult fees of $49–$99 on some plans. Henry's site does not publish a full per-plan price grid on its treatment page, so verify current pricing for your specific plan directly with Henry Meds.

Henry's disclosure practices deserve specific praise. Its GLP-1 page states outright that compounded medications "do not undergo pre-market review or an FDA-approval process," that trial data from approved drugs should not be transferred to compounded versions, and that it "exclusively works with licensed compounding pharmacies in the United States" (503A pharmacies and 503B outsourcing facilities). Henry is LegitScript certified. Two operational notes from its FAQ: eligibility runs from age 18 to 70, and multi-month plans may require paying out the balance if you cancel early for non-medical reasons.

How the Models Compare

This is the closest structural match in the batch. No membership fee on either side. One bill on either side. Compounded medication from disclosed, licensed US pharmacies on either side. Henry adds oral tablet formats — a real option for needle-averse patients that Ozari's injectable lineup doesn't cover — and publishes a peer-reviewed retrospective study of its own patient outcomes, which few telehealth brands bother to do.

The differences are the entry price, the commitment mechanics, and the ceiling. Henry's lowest advertised number is $179/month, its tracked injectable semaglutide rates sit at $247–$297, and the cheaper rate binds you for twelve months. Ozari's starter is $86/month with quarterly pricing at $145 after — and no annual lock.

The 12-Month Math

Henry, at the advertised floor: $179 × 12 = $2,148, assuming your plan and dose stay at the starting price.

Henry, at the tracker-recorded injectable semaglutide rates: $247 × 12 = $2,964 with a 12-month commitment, or $297 × 12 = $3,564 month-to-month. A $147 first month, where offered, trims those figures slightly.

Ozari's published year one:

  • Semaglutide: $257 (starter) + $145 × 9 = $1,562
  • Tirzepatide: $125 × 3 + $199 × 9 = $375 + $1,791 = $2,166

Even against Henry's best advertised number, Ozari's semaglutide year runs $586 less. Against the tracked committed rate, the gap is $1,402. Ozari's tirzepatide year ($2,166) also comes in under Henry's tracked oral tirzepatide rate ($299 × 12 = $3,588).

A note from our clinical team: We ask patients to prove a medication to themselves before they prepay for it. Twelve months is a long promise when you are still in weeks four through eight, where nausea and dose adjustments do most of their sorting. Run at least one full titration step on month-to-month billing before locking a committed rate anywhere. And if you transfer to us from a flat-rate plan, send your fill dates along with your doses — the calendar tells us as much as the milligrams do.

Key Comparison Table

Henry MedsOzari Health
Pricing modelFlat all-in monthly, varies by plan/doseFlat all-in monthly
Semaglutide priceFrom $179/mo advertised; $247–$297/mo injectable per Ozari tracker$86/mo starter, $145/mo quarterly, $175/mo monthly
Tirzepatide priceOffered; oral listed at $299/mo per Ozari tracker$125/mo starter, $199/mo quarterly, $235/mo monthly
Membership feeNoneNone
Pharmacy disclosureLicensed US 503A/503B compounding pharmacies, disclosedLicensed 503A US compounding pharmacies
CertificationLegitScript certifiedLegitScript certified
Commitment12-month commitment for lowest tracked rate; payout on early cancelStarter month-to-month; quarterly plans

Red Flags — Avoid These Providers

How to Cancel Henry Meds

Henry's help center directs cancellation and reactivation questions to its support team at ask@henrymeds.com or (909) 787-2342; check your patient portal account page first for a self-serve cancel option, then email or call if you don't see one. The refund rules are laid out in Henry's published Refunds, Returns & Replacements Policy. Per that policy as of August 2026: subscription fees are generally non-refundable once billed, dispensed medication is final sale, and the $30 medical consultation fee is non-refundable once a prescription has been issued. The notable exception covers prepaid multi-month plans — if a licensed provider documents that continuing therapy is medically contraindicated and Henry's clinical team approves, a prorated refund of the unused subscription period is available, less any processing fee. Henry's FAQ also notes multi-month plans may require paying out the remaining balance if canceled early for non-medical reasons. Cancel ahead of your billing date, put the request in writing even if you call, and screenshot the confirmation. Ozari's cancellation terms are published on its refund policy page: https://www.ozarihealth.com/refund-policy

Frequently Asked Questions

How much does Henry Meds GLP-1 treatment cost?

Henry's FAQ says plans start at $179/month, all-inclusive, varying by treatment and dose. Ozari's tracker has recorded injectable semaglutide at $247–$297/month. Verify your plan's current price directly with Henry Meds.

Does Henry Meds charge a membership fee?

No. Like Ozari, Henry bundles provider visits, medication, supplies, and support into one flat monthly price with no separate membership charge.

Is there a commitment at Henry Meds?

Per Ozari's tracker, the lower $247/month injectable semaglutide rate has required a 12-month commitment. Henry's FAQ notes multi-month plans may require paying out the remaining balance if canceled for non-medical reasons.

Are Henry's medications FDA-approved?

No, and Henry says so plainly: its compounded GLP-1s do not go through FDA pre-market review. They are prepared by licensed US 503A pharmacies and 503B outsourcing facilities on individual prescriptions.

How does Ozari's price compare over a year?

Ozari semaglutide: $1,562 year one ($257 starter, then $145 × 9). Henry's advertised floor works out to $2,148, and tracked injectable rates to $2,964–$3,564. Confirm current figures with both companies.

Who is eligible at each?

Henry accepts ages 18–70, subject to provider review. Ozari serves all 50 states via intake confirmation, with a licensed independent provider reviewing every case before any prescription.

How do I cancel Henry Meds?

Check your patient portal for a cancel option, or contact ask@henrymeds.com / (909) 787-2342 before your billing date. Subscription fees and dispensed medication are non-refundable; prepaid multi-month plans are prorated only with documented medical need approved by Henry's clinical team.

This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Always consult a licensed healthcare provider before starting any weight-loss medication. Ozari Health connects patients with licensed independent providers who determine whether treatment is appropriate.

Sources

Related Articles